Elite Capital Modaraba 1st (FECM)
Pakistan Stock Exchange (PSX) · Pakistan · prices in PKR · close of 27 Oct 2026
Key indicators
| Last close | PKR 17.48 |
|---|---|
| 52-week range | 11.75 – 56.69 |
| Return, 1 month / 3 months | −6.1% / −2.0% |
| Return, 1 year / 3 years | −69.1% / +463.9% |
| Trend | Below its 200-day average |
| RSI (14) | 37 |
| Volatility (1 year) | 71.8% |
| Worst drawdown (1 year) | -78.1% |
| Average daily value traded | 0.89M PKR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
First Elite Capital Modaraba is a modaraba that provides ijarah, musharakah and murabahah financing, alongside investment in marketable securities and trading of stock and other related businesses. A modaraba is a type of Islamic finance arrangement in which funds are pooled and managed on a profit-and-loss sharing basis by a management company, and this one is managed by Crescent Modaraba Management Company Limited.
On this site Elite Capital Modaraba 1st appears as a stock on the Pakistan Stock Exchange (PSX), code FECM, with prices in Pakistani rupees (PKR). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Elite Capital Modaraba 1st (FECM) trades on the Pakistan Stock Exchange (PSX) in Pakistan. It last closed at PKR 17.48 on 27 October 2026.
Its price-based Market X-Ray is 31 out of 100 (a weak price profile), ranking 465 of 542 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 69.1% and over the last three months it fell 2.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Pakistan Stock Exchange (PSX)
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 44 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -7.4% | ||
| From 52-week high | -69.1% | ||
| Momentum | 44 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -2.0% | ||
| 6-month return | 2.5% | ||
| 12-month return, skipping the last month | -67.1% | ||
| Stability (higher is calmer) | 8 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 71.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -78.1% | ||
| Liquidity | 28 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.89M PKR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −2.9% |
|---|---|
| 1 month | −6.1% |
| 3 months | −2.0% |
| 6 months | +2.5% |
| 1 year | −69.1% |
| 3 years | +463.9% |
| 5 years | +398.0% |
Signals
| 50-day / 200-day average | 21.27 / 18.87 |
|---|---|
| Golden / death cross (60 days) | Golden, 40 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.34 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 Oct 2021 | PKR 0.3000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Pakistan Stock Exchange (PSX); it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.